Humayun-Zakaria, N. orcid.org/0000-0001-5106-5689, Yu, M., Goel, A. et al. (9 more authors) (2026) Transcriptomic profiling of tropomyosin isoforms in bladder cancer: multi-platform sequencing and experimental validation. Scientific Reports, 16. 37672. ISSN: 2045-2322
Abstract
AbstractmRNA isoform level-based biomarkers are understudied but might complement DNA based approaches. The expression of tropomyosin isoforms differs between normal and cancer cells. Tropomyosin (TPM) isoforms generated by alternative splicing may contribute to Bladder Cancer (BC) biology, but their diagnostic potential has not been defined. We analysed RNAseq data from six independent BC datasets to predict TPM isoform expression. Predictions were validated through targeted long-read sequencing and isoform-specific quantitative PCR (qPCR) in archived tumour tissues (n = 90) and BC cell lines (n = 5). Urine samples from patients with BC (n = 12) and non-cancer controls (n = 16) were assessed for diagnostic performance. The expression ratios of 2 pairs of isoforms Tpm1.7/Tpm1.4 and Tpm4.2/Tpm4.1 were 2.4- and 1.4- fold higher in BC compared with non-BC tissues (p-value = 0.0003, 0.0005, respectively). In urine specimens, the ratio of Tpm4.2/Tpm4.1 was 2.66 times higher in cancer vs controls (p = 0.0031) and achieved 92% sensitivity and 69% specificity for BC detection. TPM isoform switching events are associated with bladder carcinogenesis. Assessment of TPM isoform expression by a non-invasive urine-based qPCR assay shows promise for BC detection and may complement existing diagnostic strategies.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © The Author(s) 2026. This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
| Keywords: | Biological Sciences; Biomedical and Clinical Sciences; Oncology and Carcinogenesis; Genetics; Biotechnology; Clinical Research; Urologic Diseases; Human Genome; Cancer Genomics; Cancer; Discovery and preclinical testing of markers and technologies; Biological and endogenous factors; Cancer |
| Dates: |
|
| Institution: | The University of Sheffield |
| Academic Units: | The University of Sheffield > Faculty of Science (Sheffield) > Department of Psychology (Sheffield) |
| Date Deposited: | 11 Nov 2026 16:56 |
| Last Modified: | 11 Nov 2026 16:56 |
| Status: | Published |
| Publisher: | Springer Science and Business Media LLC |
| Refereed: | Yes |
| Identification Number: | 10.1038/s41598-026-66033-y |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:247896 |

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)